1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antibody Drug Conjugates (ADCs) 1.2.3 Bispecific Antibodies (BsAbs) 1.2.4 Fc Engineered Antibodies 1.2.5 Antibody Fragments and Antibody-Like Proteins (AF & ALPs) 1.2.6 Biosimilar Antibody (Ab) Products 1.3 Market by Application 1.3.1 Global Next Generation Antibody Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Next Generation Antibody Therapeutics Market Perspective (2016-2027) 2.2 Next Generation Antibody Therapeutics Growth Trends by Regions 2.2.1 Next Generation Antibody Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Next Generation Antibody Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Next Generation Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Next Generation Antibody Therapeutics Industry Dynamic 2.3.1 Next Generation Antibody Therapeutics Market Trends 2.3.2 Next Generation Antibody Therapeutics Market Drivers 2.3.3 Next Generation Antibody Therapeutics Market Challenges 2.3.4 Next Generation Antibody Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Next Generation Antibody Therapeutics Players by Revenue 3.1.1 Global Top Next Generation Antibody Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Next Generation Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Next Generation Antibody Therapeutics Revenue 3.4 Global Next Generation Antibody Therapeutics Market Concentration Ratio 3.4.1 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Next Generation Antibody Therapeutics Revenue in 2020 3.5 Next Generation Antibody Therapeutics Key Players Head office and Area Served 3.6 Key Players Next Generation Antibody Therapeutics Product Solution and Service 3.7 Date of Enter into Next Generation Antibody Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Next Generation Antibody Therapeutics Breakdown Data by Type 4.1 Global Next Generation Antibody Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2022-2027) 5 Next Generation Antibody Therapeutics Breakdown Data by Application 5.1 Global Next Generation Antibody Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Next Generation Antibody Therapeutics Market Size (2016-2027) 6.2 North America Next Generation Antibody Therapeutics Market Size by Type 6.2.1 North America Next Generation Antibody Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Next Generation Antibody Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Next Generation Antibody Therapeutics Market Size by Type (2016-2027) 6.3 North America Next Generation Antibody Therapeutics Market Size by Application 6.3.1 North America Next Generation Antibody Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Next Generation Antibody Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Next Generation Antibody Therapeutics Market Size by Application (2016-2027) 6.4 North America Next Generation Antibody Therapeutics Market Size by Country 6.4.1 North America Next Generation Antibody Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Next Generation Antibody Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Next Generation Antibody Therapeutics Market Size (2016-2027) 7.2 Europe Next Generation Antibody Therapeutics Market Size by Type 7.2.1 Europe Next Generation Antibody Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Next Generation Antibody Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Next Generation Antibody Therapeutics Market Size by Type (2016-2027) 7.3 Europe Next Generation Antibody Therapeutics Market Size by Application 7.3.1 Europe Next Generation Antibody Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Next Generation Antibody Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Next Generation Antibody Therapeutics Market Size by Application (2016-2027) 7.4 Europe Next Generation Antibody Therapeutics Market Size by Country 7.4.1 Europe Next Generation Antibody Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Next Generation Antibody Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Type 8.2.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Application 8.3.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region 8.4.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Next Generation Antibody Therapeutics Market Size (2016-2027) 9.2 Latin America Next Generation Antibody Therapeutics Market Size by Type 9.2.1 Latin America Next Generation Antibody Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Next Generation Antibody Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Next Generation Antibody Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Next Generation Antibody Therapeutics Market Size by Application 9.3.1 Latin America Next Generation Antibody Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Next Generation Antibody Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Next Generation Antibody Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Next Generation Antibody Therapeutics Market Size by Country 9.4.1 Latin America Next Generation Antibody Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Next Generation Antibody Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type 10.2.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application 10.3.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country 10.4.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Next Generation Antibody Therapeutics Introduction 11.1.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Next Generation Antibody Therapeutics Introduction 11.2.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Details 11.3.2 Bristol-Myers Squibb Business Overview 11.3.3 Bristol-Myers Squibb Next Generation Antibody Therapeutics Introduction 11.3.4 Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.3.5 Bristol-Myers Squibb Recent Development 11.4 Amgen 11.4.1 Amgen Company Details 11.4.2 Amgen Business Overview 11.4.3 Amgen Next Generation Antibody Therapeutics Introduction 11.4.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.4.5 Amgen Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Next Generation Antibody Therapeutics Introduction 11.5.4 AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 Bayer 11.6.1 Bayer Company Details 11.6.2 Bayer Business Overview 11.6.3 Bayer Next Generation Antibody Therapeutics Introduction 11.6.4 Bayer Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.6.5 Bayer Recent Development 11.7 Takeda Pharmaceuticals 11.7.1 Takeda Pharmaceuticals Company Details 11.7.2 Takeda Pharmaceuticals Business Overview 11.7.3 Takeda Pharmaceuticals Next Generation Antibody Therapeutics Introduction 11.7.4 Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.7.5 Takeda Pharmaceuticals Recent Development 11.8 Biogen 11.8.1 Biogen Company Details 11.8.2 Biogen Business Overview 11.8.3 Biogen Next Generation Antibody Therapeutics Introduction 11.8.4 Biogen Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.8.5 Biogen Recent Development 11.9 Seattle Genetics 11.9.1 Seattle Genetics Company Details 11.9.2 Seattle Genetics Business Overview 11.9.3 Seattle Genetics Next Generation Antibody Therapeutics Introduction 11.9.4 Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.9.5 Seattle Genetics Recent Development 11.10 ImmunoGen 11.10.1 ImmunoGen Company Details 11.10.2 ImmunoGen Business Overview 11.10.3 ImmunoGen Next Generation Antibody Therapeutics Introduction 11.10.4 ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.10.5 ImmunoGen Recent Development 11.11 Kyowa Hakko Kirin 11.11.1 Kyowa Hakko Kirin Company Details 11.11.2 Kyowa Hakko Kirin Business Overview 11.11.3 Kyowa Hakko Kirin Next Generation Antibody Therapeutics Introduction 11.11.4 Kyowa Hakko Kirin Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.11.5 Kyowa Hakko Kirin Recent Development 11.12 Xencor 11.12.1 Xencor Company Details 11.12.2 Xencor Business Overview 11.12.3 Xencor Next Generation Antibody Therapeutics Introduction 11.12.4 Xencor Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.12.5 Xencor Recent Development 11.13 Dyax Corp 11.13.1 Dyax Corp Company Details 11.13.2 Dyax Corp Business Overview 11.13.3 Dyax Corp Next Generation Antibody Therapeutics Introduction 11.13.4 Dyax Corp Revenue in Next Generation Antibody Therapeutics Business (2016-2021) 11.13.5 Dyax Corp Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antibody Drug Conjugates (ADCs) Table 3. Key Players of Bispecific Antibodies (BsAbs) Table 4. Key Players of Fc Engineered Antibodies Table 5. Key Players of Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Table 6. Key Players of Biosimilar Antibody (Ab) Products Table 7. Global Next Generation Antibody Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Next Generation Antibody Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Next Generation Antibody Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Next Generation Antibody Therapeutics Market Share by Regions (2016-2021) Table 11. Global Next Generation Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Next Generation Antibody Therapeutics Market Share by Regions (2022-2027) Table 13. Next Generation Antibody Therapeutics Market Trends Table 14. Next Generation Antibody Therapeutics Market Drivers Table 15. Next Generation Antibody Therapeutics Market Challenges Table 16. Next Generation Antibody Therapeutics Market Restraints Table 17. Global Next Generation Antibody Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Next Generation Antibody Therapeutics Market Share by Players (2016-2021) Table 19. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Antibody Therapeutics as of 2020) Table 20. Ranking of Global Top Next Generation Antibody Therapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Next Generation Antibody Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Next Generation Antibody Therapeutics Product Solution and Service Table 24. Date of Enter into Next Generation Antibody Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Next Generation Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2016-2021) Table 28. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Next Generation Antibody Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2016-2021) Table 32. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Next Generation Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America Next Generation Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Next Generation Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America Next Generation Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Next Generation Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Next Generation Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Next Generation Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Next Generation Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Next Generation Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Next Generation Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Next Generation Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Next Generation Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Next Generation Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Next Generation Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Next Generation Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Next Generation Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Next Generation Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Next Generation Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. Pfizer Company Details Table 65. Pfizer Business Overview Table 66. Pfizer Next Generation Antibody Therapeutics Product Table 67. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 68. Pfizer Recent Development Table 69. Roche Company Details Table 70. Roche Business Overview Table 71. Roche Next Generation Antibody Therapeutics Product Table 72. Roche Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 73. Roche Recent Development Table 74. Bristol-Myers Squibb Company Details Table 75. Bristol-Myers Squibb Business Overview Table 76. Bristol-Myers Squibb Next Generation Antibody Therapeutics Product Table 77. Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 78. Bristol-Myers Squibb Recent Development Table 79. Amgen Company Details Table 80. Amgen Business Overview Table 81. Amgen Next Generation Antibody Therapeutics Product Table 82. Amgen Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 83. Amgen Recent Development Table 84. AstraZeneca Company Details Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Next Generation Antibody Therapeutics Product Table 87. AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 88. AstraZeneca Recent Development Table 89. Bayer Company Details Table 90. Bayer Business Overview Table 91. Bayer Next Generation Antibody Therapeutics Product Table 92. Bayer Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 93. Bayer Recent Development Table 94. Takeda Pharmaceuticals Company Details Table 95. Takeda Pharmaceuticals Business Overview Table 96. Takeda Pharmaceuticals Next Generation Antibody Therapeutics Product Table 97. Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 98. Takeda Pharmaceuticals Recent Development Table 99. Biogen Company Details Table 100. Biogen Business Overview Table 101. Biogen Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 102. Biogen Recent Development Table 103. Seattle Genetics Company Details Table 104. Seattle Genetics Business Overview Table 105. Seattle Genetics Next Generation Antibody Therapeutics Product Table 106. Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 107. Seattle Genetics Recent Development Table 108. ImmunoGen Company Details Table 109. ImmunoGen Business Overview Table 110. ImmunoGen Next Generation Antibody Therapeutics Product Table 111. ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 112. ImmunoGen Recent Development Table 113. Kyowa Hakko Kirin Company Details Table 114. Kyowa Hakko Kirin Business Overview Table 115. Kyowa Hakko Kirin Next Generation Antibody Therapeutics Product Table 116. Kyowa Hakko Kirin Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 117. Kyowa Hakko Kirin Recent Development Table 118. Xencor Company Details Table 119. Xencor Business Overview Table 120. Xencor Next Generation Antibody Therapeutics Product Table 121. Xencor Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 122. Xencor Recent Development Table 123. Dyax Corp Company Details Table 124. Dyax Corp Business Overview Table 125. Dyax Corp Next Generation Antibody Therapeutics Product Table 126. Dyax Corp Revenue in Next Generation Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 127. Dyax Corp Recent Development Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Global Next Generation Antibody Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Antibody Drug Conjugates (ADCs) Features Figure 3. Bispecific Antibodies (BsAbs) Features Figure 4. Fc Engineered Antibodies Features Figure 5. Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Features Figure 6. Biosimilar Antibody (Ab) Products Features Figure 7. Global Next Generation Antibody Therapeutics Market Share by Application: 2020 VS 2027 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Next Generation Antibody Therapeutics Report Years Considered Figure 12. Global Next Generation Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Next Generation Antibody Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Next Generation Antibody Therapeutics Market Share by Regions: 2020 VS 2027 Figure 15. Global Next Generation Antibody Therapeutics Market Share by Regions (2022-2027) Figure 16. Global Next Generation Antibody Therapeutics Market Share by Players in 2020 Figure 17. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Antibody Therapeutics as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2020 Figure 19. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2016-2021) Figure 20. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2022-2027) Figure 21. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Next Generation Antibody Therapeutics Market Share by Type (2016-2027) Figure 23. North America Next Generation Antibody Therapeutics Market Share by Application (2016-2027) Figure 24. North America Next Generation Antibody Therapeutics Market Share by Country (2016-2027) Figure 25. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Next Generation Antibody Therapeutics Market Share by Type (2016-2027) Figure 29. Europe Next Generation Antibody Therapeutics Market Share by Application (2016-2027) Figure 30. Europe Next Generation Antibody Therapeutics Market Share by Country (2016-2027) Figure 31. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Type (2016-2027) Figure 39. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Application (2016-2027) Figure 40. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2016-2027) Figure 41. China Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Next Generation Antibody Therapeutics Market Share by Type (2016-2027) Figure 49. Latin America Next Generation Antibody Therapeutics Market Share by Application (2016-2027) Figure 50. Latin America Next Generation Antibody Therapeutics Market Share by Country (2016-2027) Figure 51. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Type (2016-2027) Figure 55. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Application (2016-2027) Figure 56. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Country (2016-2027) Figure 57. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Next Generation Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 61. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 63. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 65. Bayer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 66. Takeda Pharmaceuticals Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 67. Biogen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 68. Seattle Genetics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 69. ImmunoGen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 70. Kyowa Hakko Kirin Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 71. Xencor Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 72. Dyax Corp Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Pfizer Roche Bristol-Myers Squibb Amgen AstraZeneca Bayer Takeda Pharmaceuticals Biogen Seattle Genetics ImmunoGen Kyowa Hakko Kirin Xencor Dyax Corp